Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Gemma Tell-Martí
Based on 18 articles published since 2009
(Why 18 articles?)
||||
Expertise Level
The expertise of Gemma Tell-Martí ranks in the
  • Top 2.1%
  • ... of 106,334 published authors worldwide on Melanoma
  • ... from 2009 through 2019
  • ... based on contributions to 18 articles on the topic.
Graphical view (beta)
Aliases Tell-Marti, Gemma   ·   Tell-Martí, G   ·   Tell-Martí, Gemma   ·   Tell-Marti, G
Work Locations
Details
Most likely:    Universitat de Barcelona      
2018
  • Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Department of Biochemistry and Molecular Genetics, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Department of Medicine, Division of Genetic Epidemiology, University of Utah School of Medicine, Salt Lake City, UT, USA. · Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Pubmed 29706638
  • Department of Pathology, Poznan University Medical Sciences and Greater Poland Cancer Center, Poznan, 60-206, Poland. · Department of Pathology, Duke University Medical Center, Durham, NC, 27710, USA. · Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA. · Department of Pathology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, 70403, Taiwan. · Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, and Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, 08193, Spain. · Department of Pathology, University of Arkansas, Little Rock, AR, 72204, USA. · Department of Pathology, Center for Dermatopathology, Freiburg, 79016, Germany. · Department of Dermatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, 70403, Taiwan. · Department of Medicine, Section of Dermatology, University of Chicago, IL, 60637, USA. · Department of Pathology, Hospital Universitari Germans Trias i Pujol, Univeristat Autònoma de Barcelona, Barcelona, 08193, Spain. · Department of Pathology, Medical University of Gdansk, Gdansk, 80-309, Poland. · Department of Pathology, Center of Oncology, M. Sklodowska-Curie Memorial Institute, Krakow, 31-115, Poland. · Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA. Electronic address: · Pubmed 29307625
  • Dermatology Department, Melanoma Unit, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Dermatology Department, Hospital Alemán, Buenos Aires, Argentina. · Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Madrid, Spain. · Biochemical and Molecular Genetics Service, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Medicine Department, Universitat de Barcelona, Barcelona, Spain. · Pubmed 28950052
2017
  • Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, U.S.A. · Duke University Medical Center, Durham, NC, U.S.A. · University of Texas Southwestern Medical Center, Dallas, TX, U.S.A. · Poznan University Medical Sciences and Greater Poland Cancer Center, Poznan, Poland. · Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, and Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain. · University of Arkansas for Medical Sciences, Little Rock, AR, U.S.A. · Department of Medicine, Section of Dermatology, University of Chicago, IL, U.S.A. · Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain. · Medical University of Gdansk, Gdansk, Poland. · Center of Oncology, M. Sklodowska-Curie Memorial Institute, Krakow, Poland. · Pubmed 28734009
  • Biochemistry and Molecular Genetics Service, Melanoma Unit, Hospital Clínic, IDIBAPS, CIBERER, Barcelona, Spain. · IDIBELL (Bellvitge Biomedical Research Institute), Centre d' Oncologia Molecular, Barcelona, Spain. · Dermatology Service, IDIBELL-Hospital Universitari de Bellvitge, Barcelona, Spain. · Dermatology Department, Melanoma Unit, Hospital Clínic, IDIBAPS, CIBERER, Barcelona, Spain. · Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), IDIBELL, Barcelona, Spain. · IDIBELL (Bellvitge Biomedical Research Institute), Centre d' Oncologia Molecular, Barcelona, Spain. Electronic address: · Pubmed 28188776
  • Dermatology Department, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Department of Dermatology, University Hospital Essen, Essen, Germany & German Cancer Consortium, Heidelberg, Germany. · Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clínic de Barcelona, Barcelona, Spain. · Pubmed 28103633
  • Experimental Cancer Genetics, The Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK. · Department of Oncology, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, UK. · Department of Medical Oncology and Targeted Therapeutics in Solid Tumors Group (IDIBAPS), Hospital Clınic de Barcelona, Barcelona, Spain. · Melanoma Unit, Radiology Service, Hospital Clınic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clınic de Barcelona, Barcelona, Spain. · Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clınic de Barcelona, IDIBAPS, Barcelona University, Barcelona, Spain. · Melanoma Unit, Radiotherapy Oncology, Hospital Clınic, IDIBAPS, Barcelona University, Barcelona, Spain. · Leiden University Medical Centre, Leiden, The Netherlands. · Laboratorio Internacional de Investigacion sobre el Genoma Humano, Universidad Nacional Autonoma de Mexico, Santiago de Queretaro, Mexico. · Biochemistry and Molecular Genetics Department, Melanoma Unit, Hospital Clinic de Barcelona, IDIBAPS, Barcelona, Spain. · Pubmed 28097802
  • Dermatology Department, Melanoma Unit, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. · Medical Sciences Department, Section of Dermatology, University of Turin, Turin, Italy. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · DISSAL, Department of Dermatology, IRCCS-AOU S. Martino-IST, University of Genoa, Genoa, Italy. · Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. · Pathology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. · Pubmed 28555837
2016
  • Melanoma Unit, Dermatology Department, Hospital Clínic De Barcelona, IDIBAPS, Universitat De Barcelona, Barcelona, Spain. · Grup D'Immunoreceptors Del Sistema Innat I Adaptatiu, Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. · Department of Dermatology, University Hospital Essen, Essen, Germany & German Cancer Consortium, Heidelberg, Germany. · Melanoma Unit, Molecular Biology and Genetics Department, Hospital Clínic De Barcelona, Barcelona, Spain. · Centro De Investigación Biomédica En Red En Enfermedades Raras (CIBERER), Valencia, Spain. · Department of Immunology, Hospital Clínic De Barcelona, Barcelona, Spain. · Department of Cell Biology, Immunology and Neurosciences, School of Medicine, University of Barcelona, Barcelona, Spain. · Pubmed 27169428
  • Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques d'August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras, Valencia, Spain3Melanoma Unit, Molecular Biology and Genetics Department, Hospital Clínic de Barcelona, Spain. · Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques d'August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain2Centro de Investigación Biomédica en Red en Enfermedades Raras, Valencia, Spain. · Department of Dermatology, Hospital Universitari Son Espases, Palma Mallorca, Spain. · Servicio de Dermatología del Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Pubmed 26650189
  • Department of Dermatology, Federal University of São Paulo, São Paulo, Brazil. · Dermatology & Biochemistry and Molecular Genetics Departments, Melanoma Unit, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · CIBER de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Pathology, Federal University of São Paulo, São Paulo, Brazil. · Pathology Service, Melanoma Unit, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · University of Barcelona, Barcelona, Spain. · Pubmed 27310877
2015
  • Department of Dermatology, Federal University of São Paulo, São Paulo, Brazil. · Melanoma Unit, Dermatology, Biochemistry and Molecular Genetics Departments, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · CIBER de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Pathology, Federal University of São Paulo, São Paulo, Brazil. · Melanoma Unit, Pathology Service, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · University of Barcelona, Barcelona, Spain. · Pubmed 25857817
  • Melanoma Unit, Department of Dermatology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain2Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, B. · Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain3Department of Biochemical and Molecular Genetics, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barc. · Department of Pathology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain. · Pubmed 25651238
  • Dermatology Department, Melanoma Unit, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Center for Networked Biomedical Research on Rare Diseases (CIBERER), Carlos III Health Institute (ISCIII), Barcelona, Spain. · Biochemical and Molecular Genetics Service, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Laboratory of Neurodegenerative Disorders, Department of Clinical and Experimental Neurology, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clínic of Barcelona, Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Barcelona, Spain. · Medicine Department, University of Barcelona (UB), Barcelona, Spain. · Pubmed 25913870
2014
  • Melanoma Unit, Hospital Clinic and IDIBAPS (Institut d'Investigacions Biomèdiques Agustí Pi i Sunyer), Barcelona, Spain. · Pubmed 24742402
Probable:    Instituto de Salud Carlos III      
2018
  • Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Department of Biochemistry and Molecular Genetics, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Department of Medicine, Division of Genetic Epidemiology, University of Utah School of Medicine, Salt Lake City, UT, USA. · Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Pubmed 29706638
  • Department of Pathology, Poznan University Medical Sciences and Greater Poland Cancer Center, Poznan, 60-206, Poland. · Department of Pathology, Duke University Medical Center, Durham, NC, 27710, USA. · Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA. · Department of Pathology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, 70403, Taiwan. · Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, and Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, 08193, Spain. · Department of Pathology, University of Arkansas, Little Rock, AR, 72204, USA. · Department of Pathology, Center for Dermatopathology, Freiburg, 79016, Germany. · Department of Dermatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, 70403, Taiwan. · Department of Medicine, Section of Dermatology, University of Chicago, IL, 60637, USA. · Department of Pathology, Hospital Universitari Germans Trias i Pujol, Univeristat Autònoma de Barcelona, Barcelona, 08193, Spain. · Department of Pathology, Medical University of Gdansk, Gdansk, 80-309, Poland. · Department of Pathology, Center of Oncology, M. Sklodowska-Curie Memorial Institute, Krakow, 31-115, Poland. · Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA. Electronic address: · Pubmed 29307625
  • Dermatology Department, Melanoma Unit, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Dermatology Department, Hospital Alemán, Buenos Aires, Argentina. · Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Madrid, Spain. · Biochemical and Molecular Genetics Service, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Medicine Department, Universitat de Barcelona, Barcelona, Spain. · Pubmed 28950052
2017
  • Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, U.S.A. · Duke University Medical Center, Durham, NC, U.S.A. · University of Texas Southwestern Medical Center, Dallas, TX, U.S.A. · Poznan University Medical Sciences and Greater Poland Cancer Center, Poznan, Poland. · Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, and Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain. · University of Arkansas for Medical Sciences, Little Rock, AR, U.S.A. · Department of Medicine, Section of Dermatology, University of Chicago, IL, U.S.A. · Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain. · Medical University of Gdansk, Gdansk, Poland. · Center of Oncology, M. Sklodowska-Curie Memorial Institute, Krakow, Poland. · Pubmed 28734009
  • Biochemistry and Molecular Genetics Service, Melanoma Unit, Hospital Clínic, IDIBAPS, CIBERER, Barcelona, Spain. · IDIBELL (Bellvitge Biomedical Research Institute), Centre d' Oncologia Molecular, Barcelona, Spain. · Dermatology Service, IDIBELL-Hospital Universitari de Bellvitge, Barcelona, Spain. · Dermatology Department, Melanoma Unit, Hospital Clínic, IDIBAPS, CIBERER, Barcelona, Spain. · Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), IDIBELL, Barcelona, Spain. · IDIBELL (Bellvitge Biomedical Research Institute), Centre d' Oncologia Molecular, Barcelona, Spain. Electronic address: · Pubmed 28188776
  • Dermatology Department, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Department of Dermatology, University Hospital Essen, Essen, Germany & German Cancer Consortium, Heidelberg, Germany. · Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clínic de Barcelona, Barcelona, Spain. · Pubmed 28103633
  • Experimental Cancer Genetics, The Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK. · Department of Oncology, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, UK. · Department of Medical Oncology and Targeted Therapeutics in Solid Tumors Group (IDIBAPS), Hospital Clınic de Barcelona, Barcelona, Spain. · Melanoma Unit, Radiology Service, Hospital Clınic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clınic de Barcelona, Barcelona, Spain. · Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clınic de Barcelona, IDIBAPS, Barcelona University, Barcelona, Spain. · Melanoma Unit, Radiotherapy Oncology, Hospital Clınic, IDIBAPS, Barcelona University, Barcelona, Spain. · Leiden University Medical Centre, Leiden, The Netherlands. · Laboratorio Internacional de Investigacion sobre el Genoma Humano, Universidad Nacional Autonoma de Mexico, Santiago de Queretaro, Mexico. · Biochemistry and Molecular Genetics Department, Melanoma Unit, Hospital Clinic de Barcelona, IDIBAPS, Barcelona, Spain. · Pubmed 28097802
  • Dermatology Department, Melanoma Unit, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. · Medical Sciences Department, Section of Dermatology, University of Turin, Turin, Italy. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · DISSAL, Department of Dermatology, IRCCS-AOU S. Martino-IST, University of Genoa, Genoa, Italy. · Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. · Pathology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. · Pubmed 28555837
2016
  • Melanoma Unit, Dermatology Department, Hospital Clínic De Barcelona, IDIBAPS, Universitat De Barcelona, Barcelona, Spain. · Grup D'Immunoreceptors Del Sistema Innat I Adaptatiu, Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. · Department of Dermatology, University Hospital Essen, Essen, Germany & German Cancer Consortium, Heidelberg, Germany. · Melanoma Unit, Molecular Biology and Genetics Department, Hospital Clínic De Barcelona, Barcelona, Spain. · Centro De Investigación Biomédica En Red En Enfermedades Raras (CIBERER), Valencia, Spain. · Department of Immunology, Hospital Clínic De Barcelona, Barcelona, Spain. · Department of Cell Biology, Immunology and Neurosciences, School of Medicine, University of Barcelona, Barcelona, Spain. · Pubmed 27169428
  • Department of Dermatology, Federal University of São Paulo, São Paulo, Brazil. · Dermatology & Biochemistry and Molecular Genetics Departments, Melanoma Unit, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · CIBER de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Pathology, Federal University of São Paulo, São Paulo, Brazil. · Pathology Service, Melanoma Unit, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · University of Barcelona, Barcelona, Spain. · Pubmed 27310877
  • Dermatology Department, Melanoma Unit, Hospital Clinic and August Pi i Sunyer Biomedical Research Institute. · Center for Networked Biomedical Research on Rare Diseases, Carlos III Health Institute. · Biochemical and Molecular Genetics Service, Hospital Clinic and August Pi i Sunyer Biomedical Research Institute. · Laboratory of Neurodegenerative Disorders, Department of Clinical and Experimental Neurology, August Pi i Sunyer Biomedical Research Institute, Hospital Clinic of Barcelona, Center for Networked Biomedical Research in Neurodegenerative Diseases. · Medicine Department, University of Barcelona, Barcelona, Spain. · Pubmed 26389780
2015
  • Department of Dermatology, Federal University of São Paulo, São Paulo, Brazil. · Melanoma Unit, Dermatology, Biochemistry and Molecular Genetics Departments, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · CIBER de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Pathology, Federal University of São Paulo, São Paulo, Brazil. · Melanoma Unit, Pathology Service, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · University of Barcelona, Barcelona, Spain. · Pubmed 25857817
  • Melanoma Unit, Department of Dermatology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain2Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, B. · Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain3Department of Biochemical and Molecular Genetics, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barc. · Department of Pathology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain. · Pubmed 25651238
  • Dermatology, Department, Melanoma Unit, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS); Center for Biomedical Network Research on Rare Diseases (CIBERER), Carlos III Health Institute (ISCIII). · Pubmed 25631192
  • Dermatology Department, Melanoma Unit, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Center for Networked Biomedical Research on Rare Diseases (CIBERER), Carlos III Health Institute (ISCIII), Barcelona, Spain. · Biochemical and Molecular Genetics Service, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Laboratory of Neurodegenerative Disorders, Department of Clinical and Experimental Neurology, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clínic of Barcelona, Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Barcelona, Spain. · Medicine Department, University of Barcelona (UB), Barcelona, Spain. · Pubmed 25913870
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 18 total) written by Gemma Tell-Martí about Melanoma:

  • Genome-wide linkage analysis in Spanish melanoma-prone families identifies a new familial melanoma susceptibility locus at 11q. 2018
  • Prognostic role of tumoral PDL1 expression and peritumoral FoxP3+ lymphocytes in vulvar melanomas. 2018
  • Melanocortin 1 receptor (MC1R) polymorphisms' influence on size and dermoscopic features of nevi. 2018
  • KIT mutations and CD117 overexpression are markers of better progression-free survival in vulvar melanomas. 2017
  • AURKA Overexpression Is Driven by FOXM1 and MAPK/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and Therapy. 2017
  • IRF4 rs12203592 functional variant and melanoma survival. 2017
  • Genomic analysis and clinical management of adolescent cutaneous melanoma. 2017
  • Amelanotic melanoma in oculocutaneous albinism: a genetic, dermoscopic and reflectance confocal microscopy study. 2017
  • Inherited functional variants of the lymphocyte receptor CD5 influence melanoma survival. 2016
  • Time and tumor type (primary or metastatic) do not influence the detection of BRAF/NRAS mutations in formalin fixed paraffin embedded samples from melanomas. 2016
Show List of Full Article Records
Google Searches

Learn more about Gemma Tell-Martí using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Universitat de Barcelona
Instituto de Salud Carlos III
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Universitat de Barcelona
2018
  • Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Department of Biochemistry and Molecular Genetics, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Department of Medicine, Division of Genetic Epidemiology, University of Utah School of Medicine, Salt Lake City, UT, USA. · Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Pubmed 29706638
  • Department of Pathology, Poznan University Medical Sciences and Greater Poland Cancer Center, Poznan, 60-206, Poland. · Department of Pathology, Duke University Medical Center, Durham, NC, 27710, USA. · Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA. · Department of Pathology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, 70403, Taiwan. · Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, and Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, 08193, Spain. · Department of Pathology, University of Arkansas, Little Rock, AR, 72204, USA. · Department of Pathology, Center for Dermatopathology, Freiburg, 79016, Germany. · Department of Dermatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, 70403, Taiwan. · Department of Medicine, Section of Dermatology, University of Chicago, IL, 60637, USA. · Department of Pathology, Hospital Universitari Germans Trias i Pujol, Univeristat Autònoma de Barcelona, Barcelona, 08193, Spain. · Department of Pathology, Medical University of Gdansk, Gdansk, 80-309, Poland. · Department of Pathology, Center of Oncology, M. Sklodowska-Curie Memorial Institute, Krakow, 31-115, Poland. · Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA. Electronic address: · Pubmed 29307625
  • Dermatology Department, Melanoma Unit, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Dermatology Department, Hospital Alemán, Buenos Aires, Argentina. · Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Madrid, Spain. · Biochemical and Molecular Genetics Service, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Medicine Department, Universitat de Barcelona, Barcelona, Spain. · Pubmed 28950052
2017
  • Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, U.S.A. · Duke University Medical Center, Durham, NC, U.S.A. · University of Texas Southwestern Medical Center, Dallas, TX, U.S.A. · Poznan University Medical Sciences and Greater Poland Cancer Center, Poznan, Poland. · Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, and Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain. · University of Arkansas for Medical Sciences, Little Rock, AR, U.S.A. · Department of Medicine, Section of Dermatology, University of Chicago, IL, U.S.A. · Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain. · Medical University of Gdansk, Gdansk, Poland. · Center of Oncology, M. Sklodowska-Curie Memorial Institute, Krakow, Poland. · Pubmed 28734009
  • Biochemistry and Molecular Genetics Service, Melanoma Unit, Hospital Clínic, IDIBAPS, CIBERER, Barcelona, Spain. · IDIBELL (Bellvitge Biomedical Research Institute), Centre d' Oncologia Molecular, Barcelona, Spain. · Dermatology Service, IDIBELL-Hospital Universitari de Bellvitge, Barcelona, Spain. · Dermatology Department, Melanoma Unit, Hospital Clínic, IDIBAPS, CIBERER, Barcelona, Spain. · Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), IDIBELL, Barcelona, Spain. · IDIBELL (Bellvitge Biomedical Research Institute), Centre d' Oncologia Molecular, Barcelona, Spain. Electronic address: · Pubmed 28188776
  • Dermatology Department, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Department of Dermatology, University Hospital Essen, Essen, Germany & German Cancer Consortium, Heidelberg, Germany. · Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clínic de Barcelona, Barcelona, Spain. · Pubmed 28103633
  • Experimental Cancer Genetics, The Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK. · Department of Oncology, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, UK. · Department of Medical Oncology and Targeted Therapeutics in Solid Tumors Group (IDIBAPS), Hospital Clınic de Barcelona, Barcelona, Spain. · Melanoma Unit, Radiology Service, Hospital Clınic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clınic de Barcelona, Barcelona, Spain. · Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clınic de Barcelona, IDIBAPS, Barcelona University, Barcelona, Spain. · Melanoma Unit, Radiotherapy Oncology, Hospital Clınic, IDIBAPS, Barcelona University, Barcelona, Spain. · Leiden University Medical Centre, Leiden, The Netherlands. · Laboratorio Internacional de Investigacion sobre el Genoma Humano, Universidad Nacional Autonoma de Mexico, Santiago de Queretaro, Mexico. · Biochemistry and Molecular Genetics Department, Melanoma Unit, Hospital Clinic de Barcelona, IDIBAPS, Barcelona, Spain. · Pubmed 28097802
  • Dermatology Department, Melanoma Unit, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. · Medical Sciences Department, Section of Dermatology, University of Turin, Turin, Italy. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · DISSAL, Department of Dermatology, IRCCS-AOU S. Martino-IST, University of Genoa, Genoa, Italy. · Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. · Pathology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. · Pubmed 28555837
2016
  • Melanoma Unit, Dermatology Department, Hospital Clínic De Barcelona, IDIBAPS, Universitat De Barcelona, Barcelona, Spain. · Grup D'Immunoreceptors Del Sistema Innat I Adaptatiu, Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. · Department of Dermatology, University Hospital Essen, Essen, Germany & German Cancer Consortium, Heidelberg, Germany. · Melanoma Unit, Molecular Biology and Genetics Department, Hospital Clínic De Barcelona, Barcelona, Spain. · Centro De Investigación Biomédica En Red En Enfermedades Raras (CIBERER), Valencia, Spain. · Department of Immunology, Hospital Clínic De Barcelona, Barcelona, Spain. · Department of Cell Biology, Immunology and Neurosciences, School of Medicine, University of Barcelona, Barcelona, Spain. · Pubmed 27169428
  • Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques d'August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras, Valencia, Spain3Melanoma Unit, Molecular Biology and Genetics Department, Hospital Clínic de Barcelona, Spain. · Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques d'August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain2Centro de Investigación Biomédica en Red en Enfermedades Raras, Valencia, Spain. · Department of Dermatology, Hospital Universitari Son Espases, Palma Mallorca, Spain. · Servicio de Dermatología del Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Pubmed 26650189
  • Department of Dermatology, Federal University of São Paulo, São Paulo, Brazil. · Dermatology & Biochemistry and Molecular Genetics Departments, Melanoma Unit, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · CIBER de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Pathology, Federal University of São Paulo, São Paulo, Brazil. · Pathology Service, Melanoma Unit, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · University of Barcelona, Barcelona, Spain. · Pubmed 27310877
2015
  • Department of Dermatology, Federal University of São Paulo, São Paulo, Brazil. · Melanoma Unit, Dermatology, Biochemistry and Molecular Genetics Departments, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · CIBER de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Pathology, Federal University of São Paulo, São Paulo, Brazil. · Melanoma Unit, Pathology Service, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · University of Barcelona, Barcelona, Spain. · Pubmed 25857817
  • Melanoma Unit, Department of Dermatology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain2Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, B. · Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain3Department of Biochemical and Molecular Genetics, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barc. · Department of Pathology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain. · Pubmed 25651238
  • Dermatology Department, Melanoma Unit, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Center for Networked Biomedical Research on Rare Diseases (CIBERER), Carlos III Health Institute (ISCIII), Barcelona, Spain. · Biochemical and Molecular Genetics Service, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Laboratory of Neurodegenerative Disorders, Department of Clinical and Experimental Neurology, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clínic of Barcelona, Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Barcelona, Spain. · Medicine Department, University of Barcelona (UB), Barcelona, Spain. · Pubmed 25913870
2014
  • Melanoma Unit, Hospital Clinic and IDIBAPS (Institut d'Investigacions Biomèdiques Agustí Pi i Sunyer), Barcelona, Spain. · Pubmed 24742402
Instituto de Salud Carlos III
2018
  • Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Department of Biochemistry and Molecular Genetics, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Department of Medicine, Division of Genetic Epidemiology, University of Utah School of Medicine, Salt Lake City, UT, USA. · Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Pubmed 29706638
  • Department of Pathology, Poznan University Medical Sciences and Greater Poland Cancer Center, Poznan, 60-206, Poland. · Department of Pathology, Duke University Medical Center, Durham, NC, 27710, USA. · Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA. · Department of Pathology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, 70403, Taiwan. · Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, and Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, 08193, Spain. · Department of Pathology, University of Arkansas, Little Rock, AR, 72204, USA. · Department of Pathology, Center for Dermatopathology, Freiburg, 79016, Germany. · Department of Dermatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, 70403, Taiwan. · Department of Medicine, Section of Dermatology, University of Chicago, IL, 60637, USA. · Department of Pathology, Hospital Universitari Germans Trias i Pujol, Univeristat Autònoma de Barcelona, Barcelona, 08193, Spain. · Department of Pathology, Medical University of Gdansk, Gdansk, 80-309, Poland. · Department of Pathology, Center of Oncology, M. Sklodowska-Curie Memorial Institute, Krakow, 31-115, Poland. · Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA. Electronic address: · Pubmed 29307625
  • Dermatology Department, Melanoma Unit, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Dermatology Department, Hospital Alemán, Buenos Aires, Argentina. · Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Madrid, Spain. · Biochemical and Molecular Genetics Service, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Medicine Department, Universitat de Barcelona, Barcelona, Spain. · Pubmed 28950052
2017
  • Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, U.S.A. · Duke University Medical Center, Durham, NC, U.S.A. · University of Texas Southwestern Medical Center, Dallas, TX, U.S.A. · Poznan University Medical Sciences and Greater Poland Cancer Center, Poznan, Poland. · Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, and Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain. · University of Arkansas for Medical Sciences, Little Rock, AR, U.S.A. · Department of Medicine, Section of Dermatology, University of Chicago, IL, U.S.A. · Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain. · Medical University of Gdansk, Gdansk, Poland. · Center of Oncology, M. Sklodowska-Curie Memorial Institute, Krakow, Poland. · Pubmed 28734009
  • Biochemistry and Molecular Genetics Service, Melanoma Unit, Hospital Clínic, IDIBAPS, CIBERER, Barcelona, Spain. · IDIBELL (Bellvitge Biomedical Research Institute), Centre d' Oncologia Molecular, Barcelona, Spain. · Dermatology Service, IDIBELL-Hospital Universitari de Bellvitge, Barcelona, Spain. · Dermatology Department, Melanoma Unit, Hospital Clínic, IDIBAPS, CIBERER, Barcelona, Spain. · Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), IDIBELL, Barcelona, Spain. · IDIBELL (Bellvitge Biomedical Research Institute), Centre d' Oncologia Molecular, Barcelona, Spain. Electronic address: · Pubmed 28188776
  • Dermatology Department, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Department of Dermatology, University Hospital Essen, Essen, Germany & German Cancer Consortium, Heidelberg, Germany. · Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clínic de Barcelona, Barcelona, Spain. · Pubmed 28103633
  • Experimental Cancer Genetics, The Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK. · Department of Oncology, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, UK. · Department of Medical Oncology and Targeted Therapeutics in Solid Tumors Group (IDIBAPS), Hospital Clınic de Barcelona, Barcelona, Spain. · Melanoma Unit, Radiology Service, Hospital Clınic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clınic de Barcelona, Barcelona, Spain. · Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clınic de Barcelona, IDIBAPS, Barcelona University, Barcelona, Spain. · Melanoma Unit, Radiotherapy Oncology, Hospital Clınic, IDIBAPS, Barcelona University, Barcelona, Spain. · Leiden University Medical Centre, Leiden, The Netherlands. · Laboratorio Internacional de Investigacion sobre el Genoma Humano, Universidad Nacional Autonoma de Mexico, Santiago de Queretaro, Mexico. · Biochemistry and Molecular Genetics Department, Melanoma Unit, Hospital Clinic de Barcelona, IDIBAPS, Barcelona, Spain. · Pubmed 28097802
  • Dermatology Department, Melanoma Unit, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. · Medical Sciences Department, Section of Dermatology, University of Turin, Turin, Italy. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · DISSAL, Department of Dermatology, IRCCS-AOU S. Martino-IST, University of Genoa, Genoa, Italy. · Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. · Pathology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. · Pubmed 28555837
2016
  • Melanoma Unit, Dermatology Department, Hospital Clínic De Barcelona, IDIBAPS, Universitat De Barcelona, Barcelona, Spain. · Grup D'Immunoreceptors Del Sistema Innat I Adaptatiu, Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. · Department of Dermatology, University Hospital Essen, Essen, Germany & German Cancer Consortium, Heidelberg, Germany. · Melanoma Unit, Molecular Biology and Genetics Department, Hospital Clínic De Barcelona, Barcelona, Spain. · Centro De Investigación Biomédica En Red En Enfermedades Raras (CIBERER), Valencia, Spain. · Department of Immunology, Hospital Clínic De Barcelona, Barcelona, Spain. · Department of Cell Biology, Immunology and Neurosciences, School of Medicine, University of Barcelona, Barcelona, Spain. · Pubmed 27169428
  • Department of Dermatology, Federal University of São Paulo, São Paulo, Brazil. · Dermatology & Biochemistry and Molecular Genetics Departments, Melanoma Unit, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · CIBER de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Pathology, Federal University of São Paulo, São Paulo, Brazil. · Pathology Service, Melanoma Unit, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · University of Barcelona, Barcelona, Spain. · Pubmed 27310877
  • Dermatology Department, Melanoma Unit, Hospital Clinic and August Pi i Sunyer Biomedical Research Institute. · Center for Networked Biomedical Research on Rare Diseases, Carlos III Health Institute. · Biochemical and Molecular Genetics Service, Hospital Clinic and August Pi i Sunyer Biomedical Research Institute. · Laboratory of Neurodegenerative Disorders, Department of Clinical and Experimental Neurology, August Pi i Sunyer Biomedical Research Institute, Hospital Clinic of Barcelona, Center for Networked Biomedical Research in Neurodegenerative Diseases. · Medicine Department, University of Barcelona, Barcelona, Spain. · Pubmed 26389780
2015
  • Department of Dermatology, Federal University of São Paulo, São Paulo, Brazil. · Melanoma Unit, Dermatology, Biochemistry and Molecular Genetics Departments, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · CIBER de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Pathology, Federal University of São Paulo, São Paulo, Brazil. · Melanoma Unit, Pathology Service, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · University of Barcelona, Barcelona, Spain. · Pubmed 25857817
  • Melanoma Unit, Department of Dermatology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain2Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, B. · Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain3Department of Biochemical and Molecular Genetics, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barc. · Department of Pathology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain. · Pubmed 25651238
  • Dermatology, Department, Melanoma Unit, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS); Center for Biomedical Network Research on Rare Diseases (CIBERER), Carlos III Health Institute (ISCIII). · Pubmed 25631192
  • Dermatology Department, Melanoma Unit, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Center for Networked Biomedical Research on Rare Diseases (CIBERER), Carlos III Health Institute (ISCIII), Barcelona, Spain. · Biochemical and Molecular Genetics Service, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Laboratory of Neurodegenerative Disorders, Department of Clinical and Experimental Neurology, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clínic of Barcelona, Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Barcelona, Spain. · Medicine Department, University of Barcelona (UB), Barcelona, Spain. · Pubmed 25913870
Unspecified
2016
  • Dermatology Department, Melanoma Unit, Hospital Clinic and August Pi i Sunyer Biomedical Research Institute. · Center for Networked Biomedical Research on Rare Diseases, Carlos III Health Institute. · Biochemical and Molecular Genetics Service, Hospital Clinic and August Pi i Sunyer Biomedical Research Institute. · Laboratory of Neurodegenerative Disorders, Department of Clinical and Experimental Neurology, August Pi i Sunyer Biomedical Research Institute, Hospital Clinic of Barcelona, Center for Networked Biomedical Research in Neurodegenerative Diseases. · Medicine Department, University of Barcelona, Barcelona, Spain. · Pubmed 26389780
Yearly article counts 03554100000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.